(secondQuint)University of Alabama at Birmingham (UAB) Adult CBD Program.

 The specific goals of this phase 1 dose finding study conducted in consecutively enrolled patients 15 years and older are to prospectively and longitudinally assess the safety and tolerability, including cognitive effects, of CBD at various doses between 5 mg/kg/day and 25 mg/kg/day with additional titration in some cases up to 50 mg/kg/day.

 In order to participate in the study, participants will need to fulfill the inclusion and exclusion criteria.

.

 University of Alabama at Birmingham (UAB) Adult CBD Program@highlight

The purpose of this study is to evaluate the safety and tolerability of Epidiolex at various doses between 5 mg/kg/day and 50 mg/kg/day as an additional (add-on) drug for treating debilitating, drug-resistant epilepsy.

